Almac is expanding its European Clinical Technologies business by opening a new European headquarters in Craigavon, Co. Armagh. The move will initially create 35 new employment opportunities in Northern Ireland.

Almac has invested approximately $3.9 million in the new facility. This expansion follows strong performance at the division, which has experienced 30% growth during the past year.

Jim Murphy, managing director at Almac Clinical Technologies HQ at Yardley, PA, said, “Our expansion in Craigavon will allow us to increase the number of client facing staff based in Europe, and will afford Clinical Technologies the opportunity to benefit from all the Almac group’s skill-set and infrastructure. Almac Clinical Technologies is a key resource for many of the world’s top pharmaceutical and biotech companies. Establishing our European HQ in Craigavon fits with our overall strategy for growth,” he added.

Almac chairman Sir Allen McClay said, “The level of investment associated with this move shows our commitment to our operations in Craigavon, as well as Almac’s long-term focus on developing fully integrated pharmaceutical services, from discovery, development, right through to delivery of commercial product.”